These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23031199)

  • 41. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
    Muramatsu S; Okuno T; Suzuki Y; Nakayama T; Kakiuchi T; Takino N; Iida A; Ono F; Terao K; Inoue N; Nakano I; Kondo Y; Tsukada H
    Synapse; 2009 Jul; 63(7):541-8. PubMed ID: 19253400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Substantia Nigra Is Permissive and Gains Inductive Signals When Lesioned for Dopaminergic Differentiation of Embryonic Stem Cells.
    Collazo-Navarrete O; Hernández-García D; Guerrero-Flores G; Drucker-Colín R; Guerra-Crespo M; Covarrubias L
    Stem Cells Dev; 2019 Aug; 28(16):1104-1115. PubMed ID: 31140356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease.
    Hedlund E; Pruszak J; Lardaro T; Ludwig W; Viñuela A; Kim KS; Isacson O
    Stem Cells; 2008 Jun; 26(6):1526-36. PubMed ID: 18388307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease.
    Wang YK; Zhu WW; Wu MH; Wu YH; Liu ZX; Liang LM; Sheng C; Hao J; Wang L; Li W; Zhou Q; Hu BY
    Stem Cell Reports; 2018 Jul; 11(1):171-182. PubMed ID: 29910127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease.
    Wulansari N; Kim EH; Sulistio YA; Rhee YH; Song JJ; Lee SH
    Stem Cell Reports; 2017 Oct; 9(4):1192-1206. PubMed ID: 28943252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease.
    Daadi MM; Grueter BA; Malenka RC; Redmond DE; Steinberg GK
    PLoS One; 2012; 7(7):e41120. PubMed ID: 22815935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.
    Sánchez-Danés A; Consiglio A; Richaud Y; Rodríguez-Pizà I; Dehay B; Edel M; Bové J; Memo M; Vila M; Raya A; Izpisua Belmonte JC
    Hum Gene Ther; 2012 Jan; 23(1):56-69. PubMed ID: 21877920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice.
    Parish CL; Castelo-Branco G; Rawal N; Tonnesen J; Sorensen AT; Salto C; Kokaia M; Lindvall O; Arenas E
    J Clin Invest; 2008 Jan; 118(1):149-60. PubMed ID: 18060047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats.
    Haobam R; Tripathy D; Kaidery NA; Mohanakumar KP
    Rejuvenation Res; 2015 Apr; 18(2):173-84. PubMed ID: 25546608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A well-refined in vitro model derived from human embryonic stem cell for screening phytochemicals with midbrain dopaminergic differentiation-boosting potential for improving Parkinson's disease.
    Hsieh WT; Chiang BH
    J Agric Food Chem; 2014 Jul; 62(27):6326-36. PubMed ID: 24933592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease.
    Zhang L; Yang H
    Mol Biol Rep; 2024 Feb; 51(1):347. PubMed ID: 38400887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration.
    Baier PC; Schindehütte J; Thinyane K; Flügge G; Fuchs E; Mansouri A; Paulus W; Gruss P; Trenkwalder C
    Stem Cells; 2004; 22(3):396-404. PubMed ID: 15153616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.
    Salti A; Nat R; Neto S; Puschban Z; Wenning G; Dechant G
    Stem Cells Dev; 2013 Feb; 22(3):397-411. PubMed ID: 22889265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys.
    Tao Y; Vermilyea SC; Zammit M; Lu J; Olsen M; Metzger JM; Yao L; Chen Y; Phillips S; Holden JE; Bondarenko V; Block WF; Barnhart TE; Schultz-Darken N; Brunner K; Simmons H; Christian BT; Emborg ME; Zhang SC
    Nat Med; 2021 Apr; 27(4):632-639. PubMed ID: 33649496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons
    Jovanovic VM; Salti A; Tilleman H; Zega K; Jukic MM; Zou H; Friedel RH; Prakash N; Blaess S; Edenhofer F; Brodski C
    J Neurosci; 2018 Feb; 38(7):1662-1676. PubMed ID: 29321139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Wrage PC; Keefer EW; Botterman BR; Tansey KE; Tansey MG
    Exp Neurol; 2008 Mar; 210(1):14-29. PubMed ID: 18061169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo.
    Moon J; Schwarz SC; Lee HS; Kang JM; Lee YE; Kim B; Sung MY; Höglinger G; Wegner F; Kim JS; Chung HM; Chang SW; Cha KY; Kim KS; Schwarz J
    Stem Cells Transl Med; 2017 Feb; 6(2):576-588. PubMed ID: 28191758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease.
    Wang M; Lu C; Roisen F
    Stem Cells Transl Med; 2012 Jun; 1(6):492-502. PubMed ID: 23197853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model.
    Steinbeck JA; Choi SJ; Mrejeru A; Ganat Y; Deisseroth K; Sulzer D; Mosharov EV; Studer L
    Nat Biotechnol; 2015 Feb; 33(2):204-9. PubMed ID: 25580598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.